Stem cell therapy may prevent PAD-related amputations

Patients with critical limb ischemia who received injections of stem cells derived from their bone marrow had a lower risk of amputation and death than patients who were not treated with the therapy in a Phase II clinical trial.

View Full Article in:

Stem Cells Improve Outlook for Severe PAD - DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ